German law makers seek to ease reimbursement for advanced therapies

The Pharma Letter

15 June 2021 - Advanced therapy trade group The Alliance for Regenerative Medicine has highlighted the passage of a new piece of legislation designed to accelerate patient access in Germany.

The legislation will reduce the so-called "NUB gap,” facilitating more NUB inquiries - a key part of the German reimbursement system for certain treatments.

Read The Pharma Letter article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Germany